Fast track admission for children with sickle cell crises. Should morphine or pethidine be given?

Comment

P Daggett. BMJ. 1998.

. 1998 Mar 21;316(7135):934; author reply 934-5.

No abstract available

Comment on

Evaluation of fast track admission policy for children with sickle cell crises: questionnaire survey of parents' preferences.
Fertleman CR, Gallagher A, Rossiter MA. Fertleman CR, et al. BMJ. 1997 Sep 13;315(7109):650. doi: 10.1136/bmj.315.7109.650. BMJ. 1997. PMID: 9310567 Free PMC article. No abstract available.
Management of patients with sickle cell disease.
Davies SC, Oni L. Davies SC, et al. BMJ. 1997 Sep 13;315(7109):656-60. doi: 10.1136/bmj.315.7109.656. BMJ. 1997. PMID: 9310570 Free PMC article. Review. No abstract available.

1. Davies SC, Oni L. Management of patients with sickle cell disease. BMJ. 1997;315:656–660. . (13 September.) - PMC - PubMed
1. Fertleman CR, Gallagher A, Rossiter MA. Evaluation of fast track admission policy for children with sickle cell crises: questionnaire survey of parents’ preferences. BMJ. 1997;315:650. . (13 September.) - PMC - PubMed
1. Fertleman CR, Gallagher A, Rossiter MA. Evaluation of fast track admission policy for children with sickle cell crises: questionnaire survey of parents’ preferences. BMJ. 1997;315:650. . (13 September.) - PMC - PubMed
1. Pryle BJ, Grech H, Stoddart PA, Carson R, O’Mahoney TO, Reynolds F. Toxicity of norpethidine in sickle cell crisis. BMJ. 1992;304:1478–1479. - PMC - PubMed
1. Pegelow CH. Survey of pain management therapy provided for children with sickle cell disease. Clin Pediatr Phila. 1992;31:211–214. - PubMed